| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 20.648 | 35.133 | 56.541 | 32.273 | 11.287 | 3.818 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 20.648 | 35.133 | 56.541 | 32.351 | 12.326 | 3.949 |
| Total Expenses - EUR | 4.677 | 218 | 139 | 2.337 | 5.138 | 7.782 | 8.814 | 21.521 | 9.985 | 4.731 |
| Gross Profit/Loss - EUR | -4.677 | -218 | -139 | -2.337 | 15.510 | 27.351 | 47.728 | 10.830 | 2.340 | -782 |
| Net Profit/Loss - EUR | -4.677 | -218 | -139 | -2.337 | 15.303 | 27.022 | 47.174 | 10.513 | 2.022 | -782 |
| Employees | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Trendpharm Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 157 | 155 | 152 | 150 | 147 | 144 | 0 | 0 | 0 | 0 |
| Current Assets | 2.828 | 2.749 | 2.688 | 1.675 | 3.945 | 27.627 | 47.999 | 18.279 | 16.365 | 9.208 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.703 | 2.676 | 4 | 15 | 180 | 814 | 1.991 | 15.800 | 8.480 | 8.024 |
| Cash | 124 | 73 | 2.684 | 1.660 | 3.765 | 26.813 | 46.008 | 2.479 | 7.886 | 1.184 |
| Shareholders Funds | -9.845 | -9.961 | -9.931 | -12.087 | 3.451 | 27.100 | 47.223 | 10.562 | 2.444 | 1.648 |
| Social Capital | 45 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 12.829 | 12.864 | 12.772 | 13.911 | 641 | 671 | 776 | 7.717 | 13.921 | 7.560 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6311 - 6311" | |||||||||
| CAEN Financial Year |
6311
|
|||||||||
Comments - Trendpharm Consulting S.r.l.